Blackstone is the world’s largest alternative asset manager. Blackstone seeks to deliver compelling returns for institutional and individual investors by strengthening the companies in which the firm invests. Blackstone’s over $1.3 trillion in assets under management
At F5, we strive to bring a better digital world to life. Our teams empower organizations across the globe to create, secure, and run applications that enhance how we experience our evolving digital world. We are
Want to be a part of Asia Pacific & Middle Easts (APME) largest, most innovative, and rapidly growing data centre company? AirTrunk is a hyperscale data centre company with a powerful purpose - to scale and
At F5, we strive to bring a better digital world to life. Our teams empower organizations across the globe to create, secure, and run applications that enhance how we experience our evolving digital world. We are
At F5, we strive to bring a better digital world to life. Our teams empower organizations across the globe to create, secure, and run applications that enhance how we experience our evolving digital world. We are
At F5, we strive to bring a better digital world to life. Our teams empower organizations across the globe to create, secure, and run applications that enhance how we experience our evolving digital world. We are
At F5, we strive to bring a better digital world to life. Our teams empower organizations across the globe to create, secure, and run applications that enhance how we experience our evolving digital world. We are
As a global leader in cybersecurity, CrowdStrike protects the people, processes and technologies that drive modern organizations. Since 2011, our mission hasn’t changed — we’re here to stop breaches, and we’ve redefined modern security with the
ポジション：Director, Drug Development Strategy (Individual Contributor) 部署：Regulatory Affairs and Drug Development Solutions (RADDS), レポート：Reports directly to RADDS Japan Head; 【部署・チーム名】 グローバルで先行していた「RADDS」（Regulatory Affairs & Drug Development Solutions）と呼ばれる新組織を日本でも始動。顧客のニーズに応じて薬事対応、開発戦略立案、臨床開発などのサービスを一体的に提供する体制を構築しました。グローバルとも連携して海外の新興バイオファーマ（EBP）を日本に呼び込むとともに、日本のバイオベンチャーの海外開発・申請をサポートします。 ポジション概要： 医薬品の製品ライフサイクル全体を見据え、臨床開発、薬事、エビデンス創出、開発品評価および事業化の観点を統合した医薬品開発戦略を策定し、クライアントの重要な意思決定を支援します。 科学的妥当性、規制上の実現可能性、商業的な目標、開発リスクおよびリソース配分を総合的に考慮し、実践的かつ価値の高い戦略的提言を提供することが本ポジションの目的です。 また、RADDS Japan Leadership Teamの一員として、医薬品開発戦略コンサルティングのケイパビリティを強化し、RADDS Japanの持続的な成長と組織運営の高度化に貢献します。 【役割への期待】 シニア戦略アドバイザーおよび医薬品開発領域のSubject